Herbalife Ltd. Announces First Quarter 2016 Results and Raises Full Year Adjusted Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Shorting Herbalife (HLF) is 'Absurdly Risky', Says Pivotal Research
May 6, 2016 8:05 AM EDTPivotal Research maintained a Buy rating on Herbalife (NYSE: HLF) with a price target of $90. Comments follow the release of strong Q1 results and an updated FTC disclosure. Analyst Timothy Ramey thinks the end game is near on the FTC matter, and he said being short Herbalife at this time is "absurdly risky."
Yesterday the company said in an SEC filing:
The outcome of these matters with the FTC, whether by mutual resolution or through litigation, could have a material adverse impact on the Companys business operations, its results of... More
UPDATE: Herbalife (HLF) Says Talks With FTC Have Progressed to Advanced Stage
May 5, 2016 4:37 PM EDT(Updated - May 5, 2016 5:28 PM EDT)
(Updated)
Herbalife (NYSE: HLF) said talks with the FTC have progressed to an advanced stage, according to Bloomberg, citing an email statement.
"While there are a number of open issues, those discussions have progressed to an advanced stage and the range of outcomes now includes litigation or settlement. If a settlement is reached with the FTC, it would likely include injunctive and other relief as well as a monetary payment with our best estimate of a payment being $200 million," the company told... More
Herbalife (HLF) Tops Q1 EPS by 27c, Raises FY EPS Guidance
May 5, 2016 4:08 PM EDTHerbalife (NYSE: HLF) reported Q1 EPS of $1.36, $0.27 better than the analyst estimate of $1.09. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.07 billion.
GUIDANCE:
Herbalife sees FY2016 EPS of $4.40-$4.75, versus prior guidance of $4.05-$4.50 and... More
